The Bigger the Ship, the Harder It Is to Turn: Continued Clinical Inertia With SGLT2i Utilization in Heart Failure

被引：0
作者：
Lyle, Melissa [1 ]
Santos-Gallego, Carlos G. [2 ]
机构：
[1] Mayo Clin, Div Adv Heart Failure & Transplant Cardiol, Jacksonville, FL 32224 USA
[2] Icahn Sch Med Mt Sinai, Cardiovasc Inst, Athero Thrombosis Res Unit, New York, NY USA
来源：
JOURNAL OF CARDIAC FAILURE | 2024年 / 30卷 / 09期
关键词：
EMPAGLIFLOZIN; OUTCOMES;
D O I：
10.1016/j.cardfail.2024.05.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1098 / 1099
页数：2
相关论文
共 41 条
  • [31] Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014-2017)
    Ito, Yuichiro
    Van Schyndle, James
    Nishimura, Takuya
    Sugitani, Toshifumi
    Kimura, Tomomi
    DIABETES THERAPY, 2019, 10 (06) : 2233 - 2249
  • [32] SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice
    Giaccari, Andrea
    Pontremoli, Roberto
    Filardi, Pasquale Perrone
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 351 : 66 - 70
  • [33] Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
    Lee, Mei-Chuan
    Hua, Yi-Ming
    Yang, Chun-Ting
    Kuo, Fang-Hsiu
    Chang, Wei-Ting
    Tang, Hsin-Ju
    Toh, Han Siong
    Lin, Yu-Min
    Chen, Sih-Yao
    Chang, Hung-Yu
    Liao, Chia-Te
    MEDICINE, 2022, 101 (51) : E32489
  • [34] Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients: a meta-analysis of randomized clinical trials
    Bazoukis, George
    Papadatos, Stamatis S.
    Thomopoulos, Costas
    Tse, Gary
    Cheilidis, Stefanos
    Tsioufis, Konstantinos
    Farmakis, Dimitrios
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (10) : 783 - 795
  • [35] Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-Analysis
    Sinha, Binayak
    Ghosal, Samit
    DIABETES THERAPY, 2019, 10 (03) : 891 - 899
  • [36] SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta-analysis of randomized clinical trials
    Oates, Connor P.
    Santos-Gallego, Carlos G.
    Smith, Alex
    Basyal, Binaya
    Moss, Noah
    Kawamura, Iwanari
    Musikantow, Daniel R.
    Turagam, Mohit K.
    Miller, Marc A.
    Whang, William
    Dukkipati, Srinivas R.
    Reddy, Vivek Y.
    Koruth, Jacob S.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 (05) : 1277 - 1285
  • [37] Chapter 2: Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection Fraction
    Ostrominski, John W.
    Vaduganathan, Muthiah
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02) : S9 - S24
  • [38] Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
    Liu, Hongyan
    Sridhar, Vikas S.
    Boulet, Jacinthe
    Dharia, Atit
    Khan, Abid
    Lawler, Patrick R.
    Cherney, David Z., I
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 126
  • [39] The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest
    Patoulias, Dimitrios
    Fragakis, Nikolaos
    Rizzo, Manfredi
    LIFE-BASEL, 2022, 12 (12):
  • [40] CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
    O'Meara, Eileen
    McDonald, Michael
    Chan, Michael
    Ducharme, Anique
    Ezekowitz, Justin A.
    Giannetti, Nadia
    Grzeslo, Adam
    Heckman, George A.
    Howlett, Jonathan G.
    Koshman, Sheri L.
    Lepage, Serge
    Mielniczuk, Lisa M.
    Moe, Gordon W.
    Swiggum, Elizabeth
    Toma, Mustafa
    Virani, Sean A.
    Zieroth, Shelley
    De, Sabe
    Matteau, Sylvain
    Parent, Marie-Claude
    Asgar, Anita W.
    Cohen, Gideon
    Fine, Nowell
    Davis, Margot
    Verma, Subodh
    Cherney, David
    Abrams, Howard
    Al-Hesayen, Abdul
    Cohen-Solal, Alain
    D'Astous, Michel
    Delgado, Diego H.
    Desplantie, Olivier
    Estrella-Holder, Estrellita
    Green, Lee
    Haddad, Haissam
    Harkness, Karen
    Hernandez, Adrian F.
    Kouz, Simon
    LeBlanc, Marie-Helene
    Lee, Douglas
    Masoudi, Frederick A.
    McKelvie, Robert S.
    Rajda, Miroslaw
    Ross, Heather J.
    Sussex, Bruce
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (02) : 159 - 169
12345